Skip to main content
BROOKS LABORATORIES LIMITED logo

BROOKS LABORATORIES LIMITED — Investor Relations & Filings

Ticker · BROOKS ISIN · INE650L01011 LEI · 984500FY0879C7971B73 BSE.NS Manufacturing
Filings indexed 498 across all filing types
Latest filing 2022-12-31 Regulatory Filings
Country IN India
Listing BSE.NS BROOKS

About BROOKS LABORATORIES LIMITED

https://www.brookslabs.net/

Brooks Laboratories Limited is a pharmaceutical manufacturing enterprise specializing in Contract Research and Manufacturing Services (CRAMS). The company focuses on the production of a diverse range of pharmaceutical formulations, including beta-lactam and non-beta-lactam products. Its portfolio encompasses various dosage forms such as dry powder injections, liquid injections, tablets, and capsules. Key therapeutic segments served include antibiotics, cardiovascular, gastrointestinal, and pain management. The company operates advanced manufacturing facilities designed to meet international quality standards, providing integrated solutions from formulation development to commercial-scale production. Brooks Laboratories emphasizes quality control and regulatory compliance to support its domestic and international client base.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is extremely short (356 characters) and contains only a digital signature with a date, without any substantive financial data, report content, or detailed information. There is no indication of a full report, announcement, or detailed filing. This matches the characteristics of a Regulatory Filing (RNS), which is a fallback category for miscellaneous filings that do not fit other categories, especially certifications or attestations without financial data.
2022-12-31 English
Updates
Regulatory Filings
2022-12-31 English
Trading Window
Regulatory Filings
2022-12-30 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal communication addressed to stock exchanges (BSE and NSE) regarding the results of a postal ballot and the scrutinizer's report. It references specific regulations under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and the Companies Act, 2013. The content includes detailed voting results and confirms that a resolution was passed by shareholders. The document is not the full report of the postal ballot but an announcement of the voting results and the scrutinizer's report. It is a typical example of a Declaration of Voting Results & Voting Rights Announcement, as it provides official results from shareholder votes conducted via postal ballot.
2022-12-30 English
Updates
Regulatory Filings
2022-12-30 English
Updates
Regulatory Filings
2022-12-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.